Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Amplia Therapeutics ( (AU:ATX) ) just unveiled an update.
Amplia Therapeutics Limited has released its corporate governance statement for the financial year ending March 31, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, detailing the roles and responsibilities of its board and management. This disclosure is crucial for stakeholders as it confirms the company’s commitment to transparency and accountability in its governance practices.
More about Amplia Therapeutics
Amplia Therapeutics Limited operates in the biotechnology industry, focusing on developing therapeutics for the treatment of cancer and fibrotic diseases. The company is committed to advancing its drug candidates through clinical trials to address unmet medical needs.
Average Trading Volume: 1,677,450
Technical Sentiment Signal: Sell
Current Market Cap: A$19.4M
For an in-depth examination of ATX stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue